You have 9 free searches left this month | for more free features.

Oxaliplatin

Showing 26 - 50 of 2,879

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Gastric Carcinoma Trial in Hanzhou (Oxaliplatin by arterial infusion plus S-1, SOX neoadjuvant, gastrectomy

Not yet recruiting
  • Locally Advanced Gastric Carcinoma
  • Oxaliplatin by arterial infusion plus S-1
  • +3 more
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Oct 20, 2022

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • Oxaliplatin
  • +5 more
  • (no location specified)
Nov 13, 2022

Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

Recruiting
  • Colonic Neoplasms
  • +2 more
  • Nanning, Guangxi, China
    The First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in Beijing (Q-1802 Injection,Oxaliplatin Injection,Capecitabine)

Recruiting
  • Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Q-1802 Injection,Oxaliplatin Injection,Capecitabine
  • Beijing, Beijing, China
    Beijing cancer hospical
Jul 27, 2023

Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +

Not yet recruiting
  • Stage I Colon Cancer
  • +2 more
  • Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
  • +2 more
  • Houston, Texas
    Baylor College of Medicine
May 22, 2023

Liver Metastases Trial in Hangzhou (Tislelizumab in Combination with Oxaliplatin and Tegafur)

Recruiting
  • Liver Metastases
  • Tislelizumab in Combination with Oxaliplatin and Tegafur
  • Hangzhou, Zhejiang, China
    gastrointestinal department of second affiliated hospital of Zhe
Jan 31, 2023

Peripheral Neuropathy, Colorectal Cancer Trial in Vejle (Fish oil, Corn oil)

Recruiting
  • Peripheral Neuropathy
  • Colorectal Cancer
  • Fish oil
  • Corn oil
  • Vejle, Denmark
    Deparment of Oncology, Vejle Hospital
Aug 8, 2022

Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)

Active, not recruiting
  • Stage III Colon Cancer
  • Oxaliplatin
  • Oxaliplatin LBM
  • Marseille, Bouches Du Rhône, France
  • +10 more
Aug 2, 2022

Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)

Completed
  • Gastric Cancer
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences
Aug 14, 2022

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • Oxaliplatin; Capecitabine
  • Oxaliplatin; Capecitabine; concurrent radiotherapy
  • Shijiazhuang, Hebei, China
    Department of General Surgery
Feb 4, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin

Recruiting
  • Hepatocellular Carcinoma
  • Raltitrexed, oxaliplatin (SALOX) treatment
  • Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
May 17, 2022

Oncology Trial (Duloxetine, Gabapentin, Lacosamide)

Not yet recruiting
  • Oncology
  • Duloxetine
  • +2 more
  • (no location specified)
Aug 19, 2022

Gastric Cancer Trial in Xi'an (Nab-paclitaxel combined with oxaliplatin and S-1)

Recruiting
  • Gastric Cancer
  • Nab-paclitaxel combined with oxaliplatin and S-1
  • Xi'an, China
    The First Affiliated Hospital of the Air Force Medical Universit
Jul 13, 2022

Colorectal Cancer Trial in Frankfurt, Zurich (Oxaliplatin, 5-Fluorouracil, Leucovorin)

Completed
  • Colorectal Cancer
  • Oxaliplatin
  • +3 more
  • Frankfurt, Germany
  • +1 more
Oct 3, 2022

Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Hepatocellular Carcinoma Resectable
  • Oxaliplatin
  • +5 more
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Mar 1, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)

Not yet recruiting
  • Colorectal Cancer
  • FOLFOX , FOLFIRI or FOLFOXIRI regimens
  • FOLFOX regimen
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Apr 26, 2023

Acetylcarnitine, Chemo-induced Peripheral Neuropathy Trial in Guangzhou (Acetyl-L-carnitine)

Not yet recruiting
  • Acetylcarnitine
  • Chemotherapy-induced Peripheral Neuropathy
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University/The First School o
Oct 28, 2022

Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Bevacizumab combined with Oxaliplatin and TAS-102
  • (no location specified)
May 16, 2022

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Advanced Biliary Tract Carcinoma Trial in Hangzhou (Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur)

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jul 6, 2022